Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT

Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT

(2016) G. A. Ulaner et al.   JOURNAL OF NUCLEAR MEDICINE

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT

(2016) Jens Sörensen et al.   Theranostics

123I-MIBG SPECT for Evaluation of Patients with Heart Failure

(2015) A. C. Dimitriu-Leen et al.   JOURNAL OF NUCLEAR MEDICINE

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

(2014) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule

(2014) J. Sorensen et al.   JOURNAL OF NUCLEAR MEDICINE

Multicenter trials using 18F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: Effects of differential measurement error and bias on power calculations for unselected and enrichment designs

(2013) Brenda F Kurland et al.   Clinical Trials

Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events

(2013) E. Karlsson et al.   EUROPEAN JOURNAL OF CANCER

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

(2013) Gaetano Aurilio et al.   EUROPEAN JOURNAL OF CANCER

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Imaging EGFR and HER2 by PET and SPECT: A Review

(2013) Emily B. Corcoran et al.   MEDICINAL RESEARCH REVIEWS

The ErbB/HER family of protein-tyrosine kinases and cancer

(2013) Robert Roskoski   PHARMACOLOGICAL RESEARCH

When to order a biopsy to characterise a metastatic relapse in breast cancer

(2012) T. Foukakis et al.   ANNALS OF ONCOLOGY

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

(2012) Javier Cortés et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

(2012) Linda Sofie Lindström et al.   JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

(2012) Sunil Verma et al.   NEW ENGLAND JOURNAL OF MEDICINE

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis

(2011) Nehmat Houssami et al.   BREAST CANCER RESEARCH AND TREATMENT

Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours

(2011) Jaap J M Teunissen et al.   ENDOCRINE-RELATED CANCER

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

(2010) Ulla Wilking et al.   BREAST CANCER RESEARCH AND TREATMENT

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

(2010) E C Dijkers et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

(2010) J. Löfblom et al.   FEBS LETTERS

Design of an Optimized Scaffold for Affibody Molecules

(2010) Joachim Feldwisch et al.   JOURNAL OF MOLECULAR BIOLOGY

Targeting of HER2-Expressing Tumors Using 111In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

(2010) S. Ahlgren et al.   JOURNAL OF NUCLEAR MEDICINE

Structural basis for high-affinity HER2 receptor binding by an engineered protein

(2010) C. Eigenbrot et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Methodological considerations in quantification of oncological FDG PET studies

(2009) Dennis Vriens et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING